The purpose and mission of the Mutation Analysis core Facility (MAF) is to help scientists at Karolinska Institutet, its associated hospitals, and other academic institutions to perform genetic, epigenetic and genetic-epidemiological research in order to identify and assess genetic factors involved in different disease processes.
Single nucleotide polymorphism (SNP) genotyping has been offered since 2003 and from 2010 we also perform targeted epigenetic analyses as well as high throughput sequencing, for a wide variety of applications, using the SOLiD system. The SNPs and methylation status are analyzed by MALDI-TOF using the SEQUENOM platform or Illumina Golden Gate technology.
MAF has achieved accreditation of our organization, facilities and the Sequenom genotyping method according to ISO/IEC 17025 by SWEDAC. MAF is the first core facility within Europe to obtain accreditation for this method.
Contact person:
Kristina Duvefelt, PhD (Lab Manager)
Tel: +46 8 58583693
email: Kristina.Duvefelt@ki.se
- Forms:
| SEQUENOM Genotyping order |  |
| SEQUENOM EpiTYPER order | |
| Sample information SEQUENOM | |
| Plate layout | |
| Order Agilent Bioanalyzer | |
| Delivery Note form |  |
- Price Lists:
| SNP genotyping - Sequenom |  | |
| Methylation - Sequenom | | |
| Zygosity analysis | | |
| DNA/RNA quality control | | |
| Genotyping - Illumina |  | |
| Next Generation Sequencing | | |
| SNP project cost calculator | |
- Resources:
 |
 |
